Psychiatry & Neurology, Clinical Neurophysiology · Marietta, GA
NPI
1295078731
Since 2013
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
780 Canton Rd NE Ste 400
Marietta, GA, 30060
Phone (770) 422-3602
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
854 services
Medicare patients, 2024
518
Average age 76
Drug cost, 2024
$2.5M
2,408 prescriptions
Company payments, 2025
$735
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Hormes was code 99214 (office e&m - established), 219 times for 173 patients. In total Joseph Hormes billed 854 services in 22 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 219 | 173 | $94.52 | $21K |
| 99204 Office E&M - New | Office | 75 | 75 | $127.82 | $9,587 |
| 99222 Hospital E&M - Initial | Facility | 70 | 69 | $104.36 | $7,305 |
| 99215 Office E&M - Established | Office | 69 | 62 | $135.33 | $9,338 |
| 95720 Neurologic | Facility | 57 | 52 | $163.53 | $9,321 |
| 95816 Neurologic | Facility | 52 | 52 | $40.15 | $2,088 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 35 | $95.75 | $4,309 |
| 99205 Office E&M - New | Office | 37 | 37 | $154.66 | $5,722 |
| 95885 Electrical Nerve Conductivity | Office | 35 | 28 | $49.94 | $1,748 |
| 95886 Electrical Nerve Conductivity | Office | 31 | 28 | $77.91 | $2,415 |
| 95819 Neurologic | Facility | 31 | 31 | $43.81 | $1,358 |
| 99232 Hospital E&M - Subsequent | Facility | 30 | 23 | $63.57 | $1,907 |
| 95813 Neurologic | Facility | 23 | 23 | $65.50 | $1,507 |
| 99213 Office E&M - Established | Office | 22 | 21 | $72.48 | $1,595 |
| 95718 Neurologic | Facility | 17 | 16 | $107.95 | $1,835 |
By year: 2022 $77K for 815 services; 2023 $67K for 712 services; 2024 $87K for 854 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Hormes prescribed most often to Medicare patients was Memantine Hcl, with 319 prescriptions and refills. In total Joseph Hormes wrote 2,408 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 319 | 497 | 72 | $6,351 |
| Levetiracetam Generic | 229 | 511 | 56 | $8,388 |
| Gabapentin Generic | 176 | 278 | 48 | $2,825 |
| Topiramate Generic | 145 | 252 | 33 | $1,545 |
| Donepezil Hcl Generic | 132 | 251 | 32 | $1,176 |
| Aimovig Autoinjector Erenumab-Aooe | 106 | 117 | 15 | $86K |
| Lacosamide Generic | 106 | 162 | 22 | $18K |
| Pregabalin Generic | 96 | 138 | 23 | $3,002 |
| Escitalopram Oxalate Generic | 94 | 168 | 25 | $764 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 82 | 160 | 20 | $1,432 |
| Amitriptyline Hcl Generic | 79 | 158 | 28 | $1,442 |
| Primidone Generic | 69 | 103 | 15 | $823 |
| Ropinirole Hcl Generic | 58 | 103 | 12 | $1,038 |
| Rizatriptan Rizatriptan Benzoate | 47 | 51 | 14 | $579 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 41 | 41 | Under 11 | $183K |
Brand drugs: 264 claims; generic drugs: 2,133 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Hormes $735 ($735 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $236.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $236 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $88.07 |
| TG Therapeutics, Inc. TGTX | 3 | $78.49 |
| SK Life Science, Inc. | 1 | $64.25 |
| Pfizer Inc. PFE | 2 | $62.52 |
| SpringWorks Therapeutics, Inc. | 1 | $30.98 |
| Celgene Corporation BMY | 1 | $28.88 |
| Axsome Therapeutics, Inc. AXSM | 1 | $26.5 |
| Amgen Inc. AMGN | 1 | $23.79 |
| Lundbeck LLC | 1 | $22.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.